Üsküdar University participates in the 12th Turkish Medical World Congress

Üsküdar University participated in the “12th Turkish Medical World Congress” held in Istanbul. Within the scope of the congress, Asst. Prof. Cihan Taştan, Director of TRGENMER, took part as a speaker in the panel titled “Domestication from Active Pharmaceutical Ingredients to Equipment: From Fragile Chain to Resilient Ecosystem”. The university delegation also attended the 2026 TÜSEB Aziz Sancar Science, Service and Incentive Awards Ceremony.

The 12th Turkish Medical World Congress, organized in Istanbul under the auspices of the Presidency by the Ministry of Health and the Turkish Health Institutes Agency (TÜSEB), brought to the agenda scientific developments in healthcare, innovative technologies, and Türkiye’s strategic goals in the health industry.

Üsküdar University was also represented at the congress, which brought together scientists, health professionals, academics, and sector representatives at national and international levels.

The congress was attended by Prof. Türker Tekin Ergüzel, Vice Rector of Üsküdar University; Prof. Haydar Sur, Advisor to the Minister of Health and Dean of the Üsküdar University Faculty of Medicine; Asst. Prof. Cihan Taştan, General Manager of Üsküdar University TRGENMER and NPCELLAB GMP and Synastra Biotechnology; and Beyza Aydın, R&D Manager of TRGENMER and NPCELLAB GMP.

Domestication and sustainable production in health technologies discussed

Within the scope of the congress, a panel titled “Domestication from Active Pharmaceutical Ingredients to Equipment: From Fragile Chain to Resilient Ecosystem” was organized by the Technology, Pharmaceutical and Domestic Industry Community (TİYSAT). 

Asst. Prof. Cihan Taştan, General Manager of Üsküdar University TRGENMER and NPCELLAB GMP and Synastra Biotechnology, took part as a speaker in the panel.

In the panel, which was also attended by Murat Börü, Bahadır Kuran, and Prof. Serdar Burmaoğlu, topics such as strengthening Türkiye’s domestic production capacity in health technologies, reducing foreign dependency in critical products and technologies, transferring research and development activities to industry, and establishing a sustainable health technologies ecosystem were evaluated.

The panel also addressed the importance of transforming scientific research into technological products, developing domestic production infrastructures, and strengthening academia-industry collaborations for the strategic needs of the health sector.

Üsküdar University Delegation also attended the TÜSEB Aziz Sancar Science Awards Ceremony

On the last day of the congress, the 2026 TÜSEB Aziz Sancar Science, Service and Incentive Awards Ceremony was held at the invitation of TÜSEB. The Üsküdar University delegation also participated in the ceremony.

In the ceremony, which featured speeches by President Recep Tayyip Erdoğan, Minister of Health Prof. Kemal Memişoğlu, and TÜSEB President Prof. Ümit Kervan, the goals of increasing Türkiye’s scientific research capacity, developing national and innovative technologies in healthcare, and strengthening the research ecosystem were emphasized.

The ceremony, which highlighted scientific achievements and contributions to the healthcare field, was an important gathering where Türkiye’s efforts in health technologies, from research to product development and production, were evaluated.

Studies conducted in the field of cell and gene therapies

The Transgenic Cell Technologies and Epigenetics Application and Research Center (TRGENMER), operating within Üsküdar University, conducts studies in advanced biotechnology and innovative treatment technologies in cooperation with NPCELLAB GMP infrastructure and Synastra Biotechnology.
Within this scope, activities are carried out on cell and gene therapies, the development of advanced therapeutic medical products, the transfer of biotechnological research to clinical applications, and the establishment of production infrastructures in compliance with Good Manufacturing Practices (GMP) standards.

With studies encompassing research, technology development, quality control, and production processes, the aim is to transform scientific knowledge into high value-added health technologies and contribute to Türkiye’s international competitiveness in innovative treatment areas.

It aims to transform scientific research into health technologies

Üsküdar University's participation in the 12th Turkish Medical World Congress and the TÜSEB Aziz Sancar Science, Service and Incentive Awards Ceremony was important in terms of connecting the university's work in health sciences and advanced biotechnology with the national health ecosystem.